Citadel Advisors’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,600
| Closed | -$110K | – | 14038 |
|
|
2025
Q1 | $110K | Buy |
7,600
+5,200
| +217% | +$73.9K | ﹤0.01% | 11328 |
|
|
2024
Q4 | $31.5K | Sell |
2,400
-1,700
| -41% | -$23.5K | ﹤0.01% | 12824 |
|
|
2024
Q3 | $47.5K | Sell |
4,100
-700
| -15% | -$6.6K | ﹤0.01% | 11968 |
|
|
2024
Q2 | $36.2K | Buy |
4,800
+2,900
| +153% | +$24K | ﹤0.01% | 12082 |
|
|
2024
Q1 | $19.1K | Sell |
1,900
-400
| -17% | -$3.72K | ﹤0.01% | 13044 |
|
|
2023
Q4 | $21.4K | Buy |
2,300
+300
| +15% | +$3.1K | ﹤0.01% | 12568 |
|
|
2023
Q3 | $25.4K | Sell |
2,000
-2,700
| -57% | -$37.1K | ﹤0.01% | 12417 |
|
|
2023
Q2 | $66.8K | Sell |
4,700
-5,300
| -53% | -$74.4K | ﹤0.01% | 11458 |
|
|
2023
Q1 | $149K | Buy |
10,000
+3,600
| +56% | +$54.5K | ﹤0.01% | 10648 |
|
|
2022
Q4 | $95.1K | Buy |
+6,400
| New | +$104K | ﹤0.01% | 11292 |
|
|
2022
Q3 | – | Sell |
-22,100
| Closed | -$464K | – | 13205 |
|
|
2022
Q2 | $464K | Buy |
22,100
+10,800
| +96% | +$220K | ﹤0.01% | 8811 |
|
|
2022
Q1 | $265K | Buy |
+11,300
| New | +$277K | ﹤0.01% | 10877 |
|
|
2021
Q4 | – | Sell |
-12,400
| Closed | -$353K | – | 14371 |
|
|
2021
Q3 | $353K | Sell |
12,400
-17,400
| -58% | -$530K | ﹤0.01% | 10701 |
|
|
2021
Q2 | $898K | Sell |
29,800
-7,700
| -21% | -$227K | ﹤0.01% | 8636 |
|
|
2021
Q1 | $955K | Sell |
37,500
-71,700
| -66% | -$1.84M | ﹤0.01% | 8240 |
|
|
2020
Q4 | $2.68M | Buy |
109,200
+87,200
| +396% | +$1.64M | ﹤0.01% | 4768 |
|
|
2020
Q3 | $358K | Buy |
22,000
+2,200
| +11% | +$40.9K | ﹤0.01% | 7840 |
|
|
2020
Q2 | $339K | Buy |
19,800
+8,100
| +69% | +$120K | ﹤0.01% | 7715 |
|
|
2020
Q1 | $136K | Sell |
11,700
-25,700
| -69% | -$530K | ﹤0.01% | 8377 |
|
|
2019
Q4 | $1.04M | Buy |
37,400
+28,100
| +302% | +$705K | ﹤0.01% | 5510 |
|
|
2019
Q3 | $210K | Sell |
9,300
-2,400
| -21% | -$54.7K | ﹤0.01% | 8092 |
|
|
2019
Q2 | $295K | Buy |
11,700
+2,200
| +23% | +$59.1K | ﹤0.01% | 7610 |
|
|
2019
Q1 | $258K | Buy |
+9,500
| New | +$319K | ﹤0.01% | 7840 |
|
|
2018
Q3 | – | Sell |
-10,200
| Closed | -$441K | – | 9517 |
|
|
2018
Q2 | $441K | Sell |
10,200
-3,000
| -23% | -$144K | ﹤0.01% | 6576 |
|
|
2018
Q1 | $734K | Buy |
13,200
+3,100
| +31% | +$170K | ﹤0.01% | 5257 |
|
|
2017
Q4 | $540K | Buy |
10,100
+5,000
| +98% | +$236K | ﹤0.01% | 5534 |
|
|
2017
Q3 | $220K | Buy |
5,100
+1,500
| +42% | +$71.3K | ﹤0.01% | 6553 |
|
|
2017
Q2 | $217K | Buy |
+3,600
| New | +$213K | ﹤0.01% | 6441 |
|
|
2017
Q1 | – | Sell |
-3,800
| Closed | -$253K | – | 7801 |
|
|
2016
Q4 | $253K | Buy |
+3,800
| New | +$247K | ﹤0.01% | 5922 |
|
|
2016
Q2 | – | Sell |
-5,100
| Closed | -$330K | – | 7158 |
|
|
2016
Q1 | $330K | Sell |
5,100
-2,500
| -33% | -$166K | ﹤0.01% | 4978 |
|
|
2015
Q4 | $545K | Buy |
7,600
+2,800
| +58% | +$207K | ﹤0.01% | 4354 |
|
|
2015
Q3 | $369K | Buy |
4,800
+500
| +12% | +$40.3K | ﹤0.01% | 5258 |
|
|
2015
Q2 | $319K | Sell |
4,300
-2,500
| -37% | -$180K | ﹤0.01% | 5661 |
|
|
2015
Q1 | $493K | Sell |
6,800
-6,200
| -48% | -$431K | ﹤0.01% | 4936 |
|
|
2014
Q4 | $859K | Buy |
13,000
+10,000
| +333% | +$610K | ﹤0.01% | 3948 |
|
|
2014
Q3 | $164K | Buy |
3,000
+100
| +3% | +$5.67K | ﹤0.01% | 5931 |
|
|
2014
Q2 | $169K | Sell |
2,900
-2,000
| -41% | -$118K | ﹤0.01% | 5741 |
|
|
2014
Q1 | $304K | Sell |
4,900
-900
| -16% | -$52.4K | ﹤0.01% | 5001 |
|
|
2013
Q4 | $310K | Buy |
+5,800
| New | +$311K | ﹤0.01% | 4568 |
|
Other funds holding MD
VPM
VCM
WA
Citadel Advisors's MD Position: Q1 2026 in Review
Citadel Advisors reduced its Pediatrix Medical (MD) stake by 6.5% in Q1 2026, selling an estimated $105K and leaving 73,000 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #6626.
Citadel Advisors first reported a position in MD in Q2 2013 and has held it in 45 quarters since. The position peaked at $45.4M in Q3 2018. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Citadel Advisors held 73,000 shares of Pediatrix Medical worth $1.56M as of Q1 2026.
- Citadel Advisors sold 5,060 Pediatrix Medical shares in Q1 2026, an estimated $105K.
- Pediatrix Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6626 holding.
- Citadel Advisors first reported a position in Pediatrix Medical in Q2 2013 and has held it in 45 quarters since.
- Citadel Advisors's Pediatrix Medical position peaked at $45.4M in Q3 2018.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.